Terkko Navigator / Lancet Infectious Diseases

Neonatal rotavirus vaccine (RV3-BB) immunogenicity and safety in a neonatal and infant administration schedule in Malawi: a randomised, double-blind, four-arm parallel group dose-ranging study

Treating pharyngeal gonorrhoea continues to remain a challenge

In-hospital mortality of patients with severe bloodstream infection: only the tip of the iceberg

Efficacy of ertapenem, gentamicin, fosfomycin, and ceftriaxone for the treatment of anogenital gonorrhoea (NABOGO): a randomised, non-inferiority trial

Development and validation of BLOOMY prediction scores for 14-day and 6-month mortality in hospitalised adults with bloodstream infections: a multicentre, prospective, cohort study

Fluid therapy for severe malaria

Time for Africa to future-proof, starting with COVID-19

The origin of SARS-CoV-2 variants of concern

Correction to Lancet Infect Dis 2022; 22: 31

Allergic bronchopulmonary aspergillosis with chest pain as atypical symptoms

A clinical case definition of post-COVID-19 condition by a Delphi consensus

The European clinical research response to optimise treatment of patients with COVID-19: lessons learned, future perspective, and recommendations

Safety and immunogenicity of the Vi-DT typhoid conjugate vaccine in healthy volunteers in Nepal: an observer-blind, active-controlled, randomised, non-inferiority, phase 3 trial

Towards a marketplace for Vi polysaccharide-conjugate typhoid vaccines

Global burden and trends of sexually transmitted infections from 1990 to 2019: an observational trend study

Routine universal testing versus selective or incidental testing for oropharyngeal Chlamydia trachomatis in women in the Netherlands: a retrospective cohort study

Pharyngeal screening for Chlamydia trachomatis, more harm than good?

Mass drug administration of ivermectin and dihydroartemisinin–piperaquine against malaria in settings with high coverage of standard control interventions: a cluster-randomised controlled trial in The Gambia

Ivermectin for mass drug administration against malaria

Global health systems' data science approach for precision diagnosis of sepsis in early life

Using big data and mobile health to manage diarrhoeal disease in children in low-income and middle-income countries: societal barriers and ethical implications

Emerging SARS-CoV-2 variants: shooting the messenger

Booster doses for inactivated COVID-19 vaccines: if, when, and for whom

Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials

Vaxxers: The Inside Story of the Oxford AstraZeneca Vaccine and the Race Against the Virus, Sarah Gilbert, Catherine Green. Hodder & Stoughton (2021), 352, £12·00, ISBN: 978-1529369854

Serial antigen rapid testing in staff of a large acute hospital

Global Health Security: A Blueprint for the Future, Lawrence Gostin. Harvard University Press (2021), 304, £36·90, ISBN: 978-0674976610

Effect of preventive chemotherapy with praziquantel on schistosomiasis among school-aged children in sub-Saharan Africa: a spatiotemporal modelling study

Neisseria meningitidis-induced discitis at L5-S1 mimicking lumbar disc herniation

Chronic cavitary pulmonary aspergillosis in an infant

Global emergence of SARS-CoV-2 variants: new foresight needed for improved vaccine efficacy

SARS-CoV-2 delta variant: a persistent threat to the effectiveness of vaccines

Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial

Effectiveness of an inactivated virus-based SARS-CoV-2 vaccine, BBV152, in India: a test-negative, case-control study

Correction to Lancet Infect Dis 2021; 21: 1097–106

Assessment of experimental malaria vaccine induced protection in pre-exposed populations

Safety and efficacy of a three-dose regimen of Plasmodium falciparum sporozoite vaccine in adults during an intense malaria transmission season in Mali: a randomised, controlled phase 1 trial

Tuberculosis screening among ambulatory people living with HIV: a systematic review and individual participant data meta-analysis

Correction to Lancet Infect Dis 2021; 21: 1485–86

Assessment of epidemiological and genetic characteristics and clinical outcomes of resistance to bedaquiline in patients treated for rifampicin-resistant tuberculosis: a cross-sectional and longitudinal study

The potential perils of a drug protection framework in tuberculosis

Efficacy, immunogenicity, and safety of a quadrivalent HPV vaccine in men: results of an open-label, long-term extension of a randomised, placebo-controlled, phase 3 trial

Save our only planet

Correction to Lancet Infect Dis 2021; 21: 1491–92

Infection control in the intensive care unit: expert consensus statements for SARS-CoV-2 using a Delphi method

Regional differences in carbapenem-resistant Klebsiella pneumoniae

Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study

Protective immunity after recovery from SARS-CoV-2 infection

COVID-19 vaccination in pregnancy—number needed to vaccinate to avoid harm

Correction to Lancet Infect Dis 2021; published online Oct 28. https://doi.org/10.1016/S1473-3099(21)00648-4